Model
Edge
Telomir Pharmaceuticals Inc.
0001971532
Filing Type
5
Filing Date
2/3/2025
Updated
2/4/25, 2:05 PM
Filing
5
Earnings Release
Exhibits
5
Statement of Changes in Beneficial Ownership